Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, January 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 110 articles: HTML format

Single Articles

1. CAMPBELL C, Singh K, Weems M, Philip R, et al
   Pulmonary hypertension in infancy: a reversible cause.
   BMJ Case Rep. 2025;18:e263731.
   PubMed    
   Abstract available
   
   

2. NISHIKIMI T, Kinoshita H, Inazumi H, Kanamori T, et al
   Adrenomedullin in pulmonary hypertension.
   Dan Med J. 2024;71:A07240498.
   PubMed    
   Abstract available
   
   

3. LACERDA TEIXEIRA B, Albuquerque F, Santos R, Ferreira A, et al
   Right ventricular myocardial work: proof-of-concept for the assessment of pressure-strain loops of patients with pre-capillary pulmonary hypertension.
   Cardiovasc Ultrasound. 2025;22:16.
   PubMed    
   Abstract available
   
   

4. FUJII H, Taniguchi Y, Tamura Y, Sakamoto M, et al
   Association between the prognosis and comorbidity of active cancer in chronic thromboembolic pulmonary hypertension.
   BMC Pulm Med. 2025;25:2.
   PubMed    
   Abstract available
   
   

5. NATHAN SD, Stinchon MR Jr, Atcheson S, Simone L, et al
   Shining a spotlight on pulmonary hypertension associated with interstitial lung disease care: The latest advances in diagnosis and treatment.
   J Manag Care Spec Pharm. 2025;31.
   PubMed    
   Abstract available
   
   

6. OROZCO-LEVI M, Souza R, Bluro IM, Harley J, et al
   Pathway to care, treatment and disease burden of pulmonary arterial hypertension: a real-world survey of physicians and patients in Latin America.
   BMJ Open. 2024;14:e087263.
   PubMed    
   Abstract available
   
   

7. MA H, Wu H, Sun X, Wang Q, et al
   The Evaluation of Right Ventricular Synchrony by Two-Dimensional Speckle Tracking Echocardiography in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
   Echocardiography. 2025;42:e70060.
   PubMed    
   Abstract available
   
   

8. ZHANG Z, Liang Y, Mo S, Zhao M, et al
   Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats.
   Physiol Rep. 2025;13:e70174.
   PubMed    
   Abstract available
   
   

9. KOMURA N, Sugano T, Ono F, Nakayama M, et al
   Effect of balloon pulmonary angioplasty on chronic thromboembolic pulmonary hypertension: an assessment of the learning curve in a Japanese university hospital.
   Cardiovasc Interv Ther. 2024 Dec 30. doi: 10.1007/s12928-024-01076.
   PubMed    
   Abstract available
   
   

10. MORIIZUMI T, Hiraide T, Momoi M, Shinya Y, et al
    Rapid Reversal of Pulmonary Hypertension by High-Dose Thiamine Supplementation: A Case Report.
    CJC Open. 2024;6:1534-1537.
    PubMed    
    
    
    

11. SINGHI AK, Banerji A, Biswas N, Das S, et al
    Diagnostic enigma of pulmonary hypertension: Tale from a series of three patients.
    Med J Armed Forces India. 2024;80.
    PubMed    
    Abstract available
    
    

12. ALHARBI S, Alturaif N, Mostafa Y, Alfhaid A, et al
    Pulmonary hypertension post-liver transplant: A case report.
    World J Gastrointest Surg. 2024;16:3875-3880.
    PubMed    
    Abstract available
    
    

13. ZHANG CY, Hu YS, Meng ZY, Lu CH, et al
    Development and validation of a mortality predictive model for ICU patients with primary pulmonary hypertension.
    Sci Rep. 2024;14:31497.
    PubMed    
    Abstract available
    
    

14. LI C, Li C, Jiang Y, Liu M, et al
    Hypoxia-induced TPC2 transcription and glycosylation aggravates pulmonary arterial hypertension by blocking autophagy flux.
    Sci Rep. 2024;14:31223.
    PubMed    
    Abstract available
    
    

15. SI Y, Huang H, Pan J, Luo X, et al
    Identification of potential biomarkers and pathways involved in high-altitude pulmonary edema using GC-MS and LC-MS metabolomic methods.
    Sci Rep. 2024;14:30978.
    PubMed    
    Abstract available
    
    

16. YU H, Song H, Li J, Cui L, et al
    Identification of Anoikis-related potential biomarkers and therapeutic drugs in chronic thromboembolic pulmonary hypertension via bioinformatics analysis and in vitro experiment.
    Sci Rep. 2024;14:30663.
    PubMed    
    Abstract available
    
    

17. ZHANG S, Wang N, Ma H, Jing L, et al
    A stable rat model of high altitude pulmonary edema established by hypobaric hypoxia combined diurnal temperature fluctuation and exercise.
    Biochem Biophys Res Commun. 2025;744:151193.
    PubMed    
    Abstract available
    
    

18. SHI W, Han MY, Chen Z, Cheng XY, et al
    [Clinical characteristics and risk factors for adverse outcomes in omphalocele].
    Zhonghua Er Ke Za Zhi. 2025;63:43-49.
    PubMed    
    Abstract available
    
    

19. AFSIN H, Afsin E, Cosgun Z
    Comparison of ventilation/perfusion scintigraphy and pulmonary CT angiography: Findings in the diagnosis of CTEPH and CTED.
    Hell J Nucl Med. 2024;27:188-197.
    PubMed    
    Abstract available
    
    

20. LEITE LB, Soares LL, Portes AMO, da Silva BAF, et al
    Combined exercise hinders the progression of pulmonary and right heart harmful remodeling in monocrotaline-induced pulmonary arterial hypertension.
    J Appl Physiol (1985). 2025;138:182-194.
    PubMed    
    Abstract available
    
    

21. LU S, Starr LJ, Taylor RA, Yetman AT, et al
    Bullous Lung Disease in Turner Syndrome: An Underrecognized Comorbidity?
    Am J Med Genet A. 2025;197:e63908.
    PubMed    
    Abstract available
    
    

22. YE P, Jiang XM, Qian WC, Zhang J, et al
    Inhibition of PCSK9 Improves the Development of Pulmonary Arterial Hypertension Via Down-Regulating Notch3 Expression.
    Cardiovasc Drugs Ther. 2024;38:1223-1234.
    PubMed    
    Abstract available
    
    

23. SONG D, Wang M, Zhao X, Zhang Y, et al
    Aldose Reductase: A Promising Therapeutic Target for High-Altitude Pulmonary Edema.
    Int J Mol Sci. 2025;26:341.
    PubMed    
    Abstract available
    
    

24. HAMURO A, Kasuga Y, Saito S, Uchida H, et al
    Pregnancy complicated by fetal goiter following lung transplantation for idiopathic pulmonary arterial hypertension: A case study.
    Taiwan J Obstet Gynecol. 2025;64:131-133.
    PubMed    
    Abstract available
    
    

25. QIANWEN W, Huangshu Y, Hong M, Xiaoxia G, et al
    The Prognostic Value of Right Ventricular End-Diastolic Basal Diameter Index by Echocardiography in Connective Tissue Diseases Associated With Pulmonary Artery Hypertension.
    Int J Rheum Dis. 2025;28:e70061.
    PubMed    
    Abstract available
    
    

26. KAWASHIMA M, Konoeda C, Yamamoto K, Sato M, et al
    Improved Pulmonary Hypertension and Heart Failure by Diaphragmatic Plication and Tracheal Resection.
    Ann Thorac Surg Short Rep. 2024;2:636-639.
    PubMed    
    Abstract available
    
    

27. MELZIG C, Weinheimer O, Egenlauf B, Do TD, et al
    Automated volumetry of core and peel intrapulmonary vasculature on computed tomography angiography for non-invasive estimation of hemodynamics in patients with pulmonary hypertension (2022 updated hemodynamic definition).
    Cardiovasc Diagn Ther. 2024;14:1083-1095.
    PubMed    
    Abstract available
    
    

28. CAI X, Wei Z, Shen Y, Qian L, et al
    Pulmonary artery denervation by noninvasive stereotactic radiotherapy: a pilot study in swine models of pulmonary hypertension.
    Nat Commun. 2025;16:558.
    PubMed    
    Abstract available
    
    

29. IVANOV SN, Chernyavsky AM, Edemsky AG, Vasiltseva OY, et al
    [Chronic Thromboembolic Pulmonary Hypertension Drug Treatment].
    Kardiologiia. 2024;64:77-85.
    PubMed    
    Abstract available
    
    

30. SMITH MA, Fineman JR
    New Insights Into Pediatric Pulmonary Hypertension From Bogota: Is Younger Always Better?
    Pulm Circ. 2025;15:e70039.
    PubMed    
    
    
    

31. TOMASZEWSKI M, Styczen A, Krysa M, Michalski A, et al
    Lymphocyte Involvement in the Pathology of Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2024;25:13455.
    PubMed    
    Abstract available
    
    

32. JANIC M, Skrgat S, Harlander M, Lunder M, et al
    Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
    Medicina (Kaunas). 2024;60:2030.
    PubMed    
    Abstract available
    
    

33. LEY L, Wiedenroth CB, Guth S, Gold C, et al
    The Diagnostic Accuracy of an Electrocardiogram in Pulmonary Hypertension and the Role of "R V1, V2 + S I, aVL - S V1".
    J Clin Med. 2024;13:7613.
    PubMed    
    Abstract available
    
    

34. PARK DH, Fuge J, Kamp JC, Harrigfeld B, et al
    Reassessing Pulmonary Hypertension Classification: Utilizing Criteria for Heart Failure with Preserved Ejection Fraction Instead of Pulmonary Arterial Wedge Pressure.
    J Clin Med. 2024;13:7582.
    PubMed    
    Abstract available
    
    

35. NEPPALA S, Chigurupati HD, Fath A, Jagirdhar GSK, et al
    Impact of pulmonary hypertension on short and long-term outcome after mitral transcatheter edge-to-edge repair: A meta-analysis.
    Cardiovasc Revasc Med. 2025 Jan 2:S1553-8389(24)00757.
    PubMed    
    Abstract available
    
    

36. FARKOUH C, Chaouat A, Guillaumot A, Baptista BR, et al
    Pulmonary hypertension in patients with chronic obstructive pulmonary disease: Impact of lung hyperinflation on the response to pulmonary hypertension treatment.
    Respir Med Res. 2024;87:101153.
    PubMed    
    Abstract available
    
    

37. KOLESNIKOVA PS, Pavlova OS, Gulyaev MV, Kuropatkina TA, et al
    Magnetic Resonance Imaging of Monocrotaline-Induced Pulmonary Hypertension in Rats Using Radial Scanning with Retrospective Gating.
    Bull Exp Biol Med. 2025 Jan 6. doi: 10.1007/s10517-025-06316.
    PubMed    
    Abstract available
    
    

38. WEI F, Lin Z, Lu W, Luo H, et al
    Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension.
    Hypertension. 2025 Jan 6. doi: 10.1161/HYPERTENSIONAHA.124.22948.
    PubMed    
    Abstract available
    
    

39. BHAT MM, Hussain MS, Bisht AS, Agrawal M, et al
    Frontiers in Pulmonary Hypertension: A Comprehensive Insight of Etiological Advances.
    Curr Rev Clin Exp Pharmacol. 2024.
    PubMed    
    Abstract available
    
    

40. DENG H, Wang P, Liu M
    The prognostic value of pulmonary hypertension in intensive care unit patients from Beth Israel Deaconess Medical Center (BIDMC).
    J Cardiothorac Surg. 2025;20:29.
    PubMed    
    Abstract available
    
    

41. SHI Y, Wu D, Chen L, Shi Y, et al
    Analysis of the clinical characteristics and outcomes of pregnant women with different degrees of pulmonary hypertension.
    J Matern Fetal Neonatal Med. 2025;38:2352090.
    PubMed    
    Abstract available
    
    

42. HOU P, Chen H, Liang S, Guo W, et al
    Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension.
    J Nucl Med. 2025;66:98-103.
    PubMed    
    Abstract available
    
    

43. HOEPER MM, Rosenkranz S, Badesch DB, Humbert M, et al
    Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studies.
    Respir Med. 2025;236:107910.
    PubMed    
    Abstract available
    
    

44. BUBER I, Aykota MR, Sevgican CI, Kaya D, et al
    Impact of Laparoscopic Sleeve Gastrectomy on Pulmonary Arterial Stiffness and Right Ventricular Function in Obese Patients.
    Obes Surg. 2025;35:87-92.
    PubMed    
    Abstract available
    
    

45. LI HZ, Wen S, Huang ZH, Fei HW, et al
    A prediction model of echocardiographic variables to screen for potentially correctable shunts in adult atrial septal defect-pulmonary hypertension patients.
    J Chin Med Assoc. 2025;88:71-79.
    PubMed    
    Abstract available
    
    

46. 
    Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet Respir Med. 2025;13:69-79.
    PubMed    
    Abstract available
    
    

47. WATZKER A, Alsumali A, Ferro C, Dieguez G, et al
    Economic Burden Associated with Pulmonary Arterial Hypertension in the United States.
    Pharmacoeconomics. 2025;43:83-91.
    PubMed    
    Abstract available
    
    

48. MADONNA R, Ghelardoni S
    Sotatercept in pulmonary hypertension and beyond.
    Eur J Clin Invest. 2025 Jan 18:e14386. doi: 10.1111/eci.14386.
    PubMed    
    Abstract available
    
    

49. XU Y, Liang L, Chen J, Li X, et al
    Difficult airway management in a patient with severe mitral and tricuspid regurgitation, rapid atrial fibrillation, and moderate pulmonary hypertension: a case report.
    BMC Anesthesiol. 2025;25:30.
    PubMed    
    Abstract available
    
    

50. SUN S, Mao J, Ding Y, Liu L, et al
    Hypoxia Combined With Interleukin-17 Regulates Hypoxia-Inducible Factor-1alpha/Endothelial Nitric Oxide Synthase Expression in Pulmonary Artery Endothelial Cells.
    J Cell Mol Med. 2025;29:e70289.
    PubMed    
    Abstract available
    
    

51. SUNGA CGG, Yang KC, Oyetunji S, Swenson ER, et al
    A Triple Threat: A Case Report Detailing Surgical Management for Hypertrophic Cardiomyopathy, Flail Mitral Valve and Severe Pulmonary Hypertension(dagger).
    Reports (MDPI). 2024;7:116.
    PubMed    
    Abstract available
    
    

52. MA F, Yang L, He Y, Yang Z, et al
    Symptom-related experience and sexual health of female patients with pulmonary arterial hypertension: protocol for a systematic review and qualitative meta-synthesis.
    BMJ Open. 2025;15:e089095.
    PubMed    
    Abstract available
    
    

53. MICHEL S, Pattathu J, Horer J, Kari FA, et al
    Reversed valved Potts shunt for refractory primary pulmonary arterial hypertension.
    Multimed Man Cardiothorac Surg. 2025;2025.
    PubMed    
    Abstract available
    
    

54. BARTSCH V, Gester F, Parzibut G, Maloir Q, et al
    [Idiopathic pulmonary arterial hypertension revealed by right ventricular dysfunction].
    Rev Med Liege. 2025;80:18-25.
    PubMed    
    Abstract available
    
    

55. STINE AE, Parmar J, Smith AK, Cummins Z, et al
    Simulation of clinical trials of oral treprostinil in pulmonary arterial hypertension using a virtual population.
    NPJ Syst Biol Appl. 2025;11:9.
    PubMed    
    Abstract available
    
    

56. LORENZI W, Wainstein RV, Rodrigues RP, Benedetto IG, et al
    Multimodal treatment of chronic thromboembolic pulmonary hypertension: initial experience at a university hospital in southern Brazil.
    J Bras Pneumol. 2025;50:e20240231.
    PubMed    
    
    
    

57. SOUZA FSF, Ferreira MG, Melo IA, Sa MFL, et al
    Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results from a cohort in Brazil.
    J Bras Pneumol. 2025;50:e20240147.
    PubMed    
    Abstract available
    
    

58. LUIJTEN D, van den Hout WB, Boon GJAM, Barco S, et al
    Cost-effectiveness of follow-up algorithms for chronic thromboembolic pulmonary hypertension in pulmonary embolism survivors.
    ERJ Open Res. 2025;11:00575-2024.
    PubMed    
    Abstract available
    
    

59. KIRILLOVA A, Sethuraman M, Dong X, Kirdar A, et al
    Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertension.
    ERJ Open Res. 2025;11:00486-2024.
    PubMed    
    Abstract available
    
    

60. RAWLINGS GH, Bowmer G, Armstrong I, Thompson AR, et al
    Update to: self-help cognitive behavioural therapy for anxiety in pulmonary hypertension.
    ERJ Open Res. 2025;11:00872-2024.
    PubMed    
    Abstract available
    
    

61. GEDEFAW A, Ayele YY, Wudie G, Tefera A, et al
    Prevalence of pulmonary hypertension and associated factors among rheumatic heart disease patients in Ethiopia.
    BMC Cardiovasc Disord. 2025;25:20.
    PubMed    
    Abstract available
    
    

62. DONNAN MT, McLean C, Siemienowicz M, Keating DT, et al
    Excipient lung disease with transient severe pulmonary hypertension in a healthcare professional injecting crushed oxycodone tablets.
    BMJ Case Rep. 2025;18:e260988.
    PubMed    
    Abstract available
    
    

63. LYU TT, Wang JY, Tan JS, Yang YM, et al
    Causal associations between telomere length and pulmonary arterial hypertension: A two-sample Mendelian randomization study.
    Medicine (Baltimore). 2024;103:e40407.
    PubMed    
    Abstract available
    
    

64. KANG L, Han Y, Liu C, Liu X, et al
    Sildenafil Attenuates Persistent Pulmonary Hypertension of the Newborn via Inhibiting the Growth and Migration of Pulmonary Artery Smooth Muscle Cells.
    J Surg Res. 2025;306:249-256.
    PubMed    
    Abstract available
    
    

65. PAKHATHIRATHIEN P, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
    Mortality Prediction in Newborns With Persistent Pulmonary Hypertension: A Comparison of Four Illness Severity Scores.
    Pediatr Pulmonol. 2025;60:e27484.
    PubMed    
    Abstract available
    
    

66. FU LJ, Feng JX, Sun YJ, Xu ZM, et al
    [A case of transcatheter membrane-covered stent shunt for severe pulmonary hypertension post-CHD surgery].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2025;53:69-72.
    PubMed    
    
    
    

67. KATO S, Minamitani Y, Hosokawa M, Nakashima T, et al
    Scoping review of initiation criteria for inhaled nitric oxide in preterm infants (born <34 weeks) after 7 days of age.
    BMJ Open. 2024;14:e087740.
    PubMed    
    Abstract available
    
    

68. JIANG P, Huang H, Liu Z, Xiang G, et al
    STAT6 deficiency mitigates the severity of pulmonary arterial hypertension caused by chronic intermittent hypoxia by suppressing Th2-inducing cytokines.
    Respir Res. 2025;26:13.
    PubMed    
    Abstract available
    
    

69. AHMAD A, Wang X, Li L, Liu T, et al
    Insights from 3D echocardiography: unveiling the prognostic value of RV function in pulmonary hypertension: a systematic review and meta-analysis.
    Int J Cardiovasc Imaging. 2025 Jan 13. doi: 10.1007/s10554-025-03326.
    PubMed    
    Abstract available
    
    

70. MOMOI M, Katsumata Y, Hiraide T, Shinya Y, et al
    Chronic Thromboembolic Pulmonary Hypertension as RNF213-Associated Vascular Disease.
    JACC Asia. 2024;4:1017-1019.
    PubMed    
    
    
    

71. WADDINGHAM MT, Tsuchimochi H, Sonobe T, Sequeira V, et al
    The selective serotonin reuptake inhibitor paroxetine improves right ventricular systolic function in experimental pulmonary hypertension.
    J Mol Cell Cardiol Plus. 2024;8:100072.
    PubMed    
    Abstract available
    
    

72. SUN H, Liao X, Wang S, Yuan H, et al
    5-Methylcytosine-modified circRNA-CCNL2 regulates vascular remdeling in hypoxic pulmonary hypertension through binding to FXR2.
    Int J Biol Macromol. 2025;296:139638.
    PubMed    
    Abstract available
    
    

73. PENG W, Wan G, Cheng S, Li G, et al
    Potential role of TRAF2 in pulmonary hypertension in broiler chickens and preparation and specificity analysis of its polyclonal antibody.
    Int J Biol Macromol. 2025 Jan 9:139741. doi: 10.1016/j.ijbiomac.2025.139741.
    PubMed    
    Abstract available
    
    

74. PATSIOU V, Arvanitaki A, Farmakis IT, Anthi A, et al
    Survival prospects of pulmonary arterial hypertension associated with congenital heart disease: Insights from the HOPE registry.
    Int J Cardiol. 2025;421:132894.
    PubMed    
    Abstract available
    
    

75. YANG L, Wang X, Gu B, Su D, et al
    Identifying the genetic association between rheumatoid arthritis and the risk of pulmonary arterial hypertension.
    Clin Rheumatol. 2024 Dec 6. doi: 10.1007/s10067-024-07258.
    PubMed    
    Abstract available
    
    

76. MONTEZANO AC, Kuriakose J, Hood KY, Sin YY, et al
    Ang-(1-7) and ET-1 Interplay Through Mas and ET(B) Receptor Interaction Defines a Novel Vasoprotective Mechanism.
    Hypertension. 2025;82:267-281.
    PubMed    
    Abstract available
    
    

77. CAO D, Grunig E, Sirenko Y, Radchenko G, et al
    SMAD5 as a novel gene for familial pulmonary arterial hypertension.
    Clin Sci (Lond). 2025;139:15-27.
    PubMed    
    Abstract available
    
    

78. YI K, Guo T, Wang WX, He SE, et al
    The relationship of nitric oxide synthase 3(NOS3) gene polymorphism in the risk of pulmonary arterial hypertension: A systematic review and meta-analysis.
    Nitric Oxide. 2025;154:51-76.
    PubMed    
    Abstract available
    
    

79. DI PASQUALE G, Caione N, Di Berardino A, Di Donato G, et al
    Pulmonary manifestations of juvenile vs. adult systemic sclerosis: insights into pathophysiological and clinical features.
    Pediatr Pulmonol. 2025;60:e27347.
    PubMed    
    Abstract available
    
    

80. AN Y, Xu M, Yan M, Zhang H, et al
    Erythrophagocytosis-induced ferroptosis contributes to pulmonary microvascular thrombosis and thrombotic vascular remodeling in pulmonary arterial hypertension.
    J Thromb Haemost. 2025;23:158-170.
    PubMed    
    Abstract available
    
    

81. SWIETLIK EM, Fay M, Morrell NW
    Exploring Diagnostic and Therapeutic Odyssey in Pulmonary Arterial Hypertension: Insights from In-Depth Semi-Structured Interviews.
    Respiration. 2025;104:26-39.
    PubMed    
    Abstract available
    
    

82. QIU JY, Huang SS, Liu C, Ding D, et al
    Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension.
    BMC Cardiovasc Disord. 2025;25:38.
    PubMed    
    Abstract available
    
    

83. FORD ML, Ruwanpathirana A, Britt RD Jr
    The Art(ery) of Contraction: Using Precision Cut Lung Slices to Model Pulmonary Hypertension in ARDS.
    Am J Respir Cell Mol Biol. 2025 Jan 23. doi: 10.1165/rcmb.2024-0603.
    PubMed    
    
    
    

84. PULLAMSETTI SS, Savai R
    Decoding lysosome communication.
    Science. 2025;387:359-361.
    PubMed    
    Abstract available
    
    

85. HARVEY LD, Alotaibi M, Tai YY, Tang Y, et al
    Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension.
    Science. 2025;387:eadn7277.
    PubMed    
    Abstract available
    
    

86. GROSSO G, Tognetti R, Domenech O, Della Pina A, et al
    Echocardiographic evaluation of the size of the main pulmonary artery and right pulmonary artery in dogs with pulmonary hypertension.
    J Vet Intern Med. 2025;39:e17241.
    PubMed    
    Abstract available
    
    

87. ANJUM AF, Fatima M, Anjum MB
    Improvements in Hemodynamics and Right Heart Remodeling Following Balloon Pulmonary Angioplasty Treatment in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study.
    Health Sci Rep. 2025;8:e70384.
    PubMed    
    
    
    

88. IKEDA N, Masaki K, Hosokawa K, Funakoshi K, et al
    Insights into balloon pulmonary angioplasty and the WHO functional class of chronic thromboembolic pulmonary hypertension patients: findings from the CTEPH AC registry.
    Cardiovasc Interv Ther. 2025 Jan 22. doi: 10.1007/s12928-025-01095.
    PubMed    
    Abstract available
    
    

89. KIM HC, Chandel A, King CS, Kim MJ, et al
    Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease.
    Lung. 2025;203:27.
    PubMed    
    Abstract available
    
    

90. CORTEZ M, Lopez B, Mamani J, de Maria Ibanez F, et al
    When the heart and tumours intertwine: pulmonary hypertension associated with a neuroendocrine tumour-a case report.
    Eur Heart J Case Rep. 2024;9:ytae678.
    PubMed    
    Abstract available
    
    

91. ZHU J, Zhang Z, Lei Y, Ouyang Z, et al
    The prediction value of serum anion gap for short-term mortality in pulmonary hypertension patients with sepsis: a retrospective cohort study.
    Front Med (Lausanne). 2025;11:1499677.
    PubMed    
    Abstract available
    
    

92. CHENG H, Yang H, Zhang Y, Wei Z, et al
    Association of Fibrinogen Aalpha Thr312Ala (rs6050) Polymorphism with Venous Thrombosis and Chronic Thromboembolic Pulmonary Hypertension: A Meta-Analysis.
    Clin Appl Thromb Hemost. 2025;31:10760296251314476.
    PubMed    
    Abstract available
    
    

93. AL-BITAR A, Zalzaleh MA, Al Helbawi H, Morteza MH, et al
    Heterotaxy syndrome, dextrocardia, ureteropelvic obstruction, endometriosis, and pulmonary hypertension in an adult with congenital heart defects: a case report.
    J Med Case Rep. 2025;19:28.
    PubMed    
    Abstract available
    
    

94. ZHANG X, Li J, Fu M, Geng X, et al
    Dysfunction in mitochondrial electron transport chain drives the pathogenesis of pulmonary arterial hypertension: insights from a multi-omics investigation.
    Respir Res. 2025;26:29.
    PubMed    
    Abstract available
    
    

95. XIA Y, Liu X
    The value of lung ultrasound score combined with echocardiography in assessing right heart function in patients undergoing maintenance hemodialysis and experiencing pulmonary hypertension.
    BMC Cardiovasc Disord. 2025;25:33.
    PubMed    
    Abstract available
    
    

96. PAI TW, Huang CW
    Low-dose dasatinib-induced chylothorax, pulmonary hypertension, and pericardial effusion in a patient with chronic myeloid leukemia: A case report and literature review.
    Medicine (Baltimore). 2025;104:e41328.
    PubMed    
    Abstract available
    
    

97. WANG Y, Huang R, Zhuang Y
    A Qualitative Study on the Experiences of Patients with Pulmonary Hypertension Undergoing Polypharmacy.
    Br J Hosp Med (Lond). 2024;85:1-17.
    PubMed    
    Abstract available
    
    

98. UFNAL M, Connolly K, Millegard M, Surkova E, et al
    Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.
    ESC Heart Fail. 2025 Jan 20. doi: 10.1002/ehf2.15203.
    PubMed    
    Abstract available
    
    

99. 
    Corrigendum: Obesity paradox in pulmonary hypertension secondary to chronic lung diseases.
    Chin Med J (Engl). 2025;138:252.
    PubMed    
    
    
    

100. AWAD MR, Eweda II, Ismail EM, Abdeltawab AA, et al
     The Role OF 3D echocardiography in prediction of pulmonary vascular resistance and its reversibility in simple congenital heart disease with secondary pulmonary hypertension.
     Curr Probl Cardiol. 2025;50:102983.
     PubMed    
     Abstract available
     
     

101. XU Y, Liao P, Song X, Guo W, et al
     A novel dual fixation method for improving the reliable assessment of pulmonary vascular morphology in pulmonary hypertension rats.
     Respir Res. 2025;26:26.
     PubMed    
     Abstract available
     
     

102. SHINOHARA T, Moonen JR, Chun YH, Lee-Yow YC, et al
     High Shear Stress Reduces ERG Causing Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension.
     Arterioscler Thromb Vasc Biol. 2025;45:218-237.
     PubMed    
     Abstract available
     
     

103. AVITABILE CM, Wang Y, Ash D, Flohr SJ, et al
     Ventricular Dysfunction in Patients With Congenital Diaphragmatic Hernia Who Die After Repair.
     J Pediatr Surg. 2024;60:162002.
     PubMed    
     Abstract available
     
     

104. GHOFRANI HA, Gomberg-Maitland M, Zhao L, Grimminger F, et al
     Mechanisms and treatment of pulmonary arterial hypertension.
     Nat Rev Cardiol. 2025;22:105-120.
     PubMed    
     Abstract available
     
     

105. RAO RJ, Yang J, Jiang S, El-Khoury W, et al
     Post-transcriptional regulation of IFI16 promotes inflammatory endothelial pathophenotypes observed in pulmonary arterial hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2025;328:L148-L158.
     PubMed    
     Abstract available
     
     

106. CHAOUAT A, Valentin S, Adir Y
     Phosphodiesterase-5 Inhibitors Show Promise in Improving Survival for Patients With COPD Pulmonary Hypertension: One Step Further But There Is Still a Long Way to Go.
     Chest. 2025;167:16-18.
     PubMed    
     
     
     

107. FLORES-CONNER N, Brazil M, Whittle M, Shah A, et al
     Severe Reversible Pulmonary Hypertension in a Patient with Shone Complex Presenting for Heart Transplantation.
     J Cardiothorac Vasc Anesth. 2024 Dec 27:S1053-0770(24)01010.
     PubMed    
     
     
     

108. ROSENKRANZ S, Ghofrani HA, Hoeper MM, Langleben D, et al
     Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials.
     J Heart Lung Transplant. 2025;44:135-146.
     PubMed    
     Abstract available
     
     

109. SHIROTA Y, Ohmori S, Engel JD, Moriguchi T, et al
     GATA2 participates in protection against hypoxia-induced pulmonary vascular remodeling.
     PLoS One. 2024;19:e0315446.
     PubMed    
     Abstract available
     
     

110. KRONBERGER C, Mousavi RA, Ozturk B, Willixhofer R, et al
     Correction: Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
     PLoS One. 2025;20:e0317857.
     PubMed    
     Abstract available